TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Past driving under the influence of cannabis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Body Mass Index (BMI) from baseline to Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Weight from baseline to each of the scheduled on treatment and post-treatment assessment time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Adverse Events as Assessed by Common Terminology Criteria for Adverse Events version 4.03 (CTCAE v4.03)
Endpoint domain: Adverse events/effects
Primary endpoint: change from baseline in family conflict
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: change from baseline in youth emotional problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in child academic competence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of patients achieving an objective response (CR or PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Myocardial infarction size (MIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Digital imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laser Speckle imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of the DYNAMO-PSY program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diagnostic performance for HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference of the parental resilience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference of the positive parenting practices
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Difference of child abuse potential
Endpoint domain: Adverse events/effects
Primary endpoint: Side effects as reported by participants
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to the training programme
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient-reported experience measures (PREMs)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Residual disease and/or upstaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prosthesis Evaluation Questionnaire - Well Being (PEQ-WB)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Spinal Cord Injury-Motor Index (SCI MovIN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting glycemic and insulin resistance profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in cognitive function (executive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in cognitive function (attention)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in cognitive function (memory)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in dysfunctional beliefs ascription
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Timeline Follow-back (TLFB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cervical lesions detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in spinal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ankylosing spondylitis disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck Disability index (NDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assessment of quality of life in older adults and people with disabilities
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tracking falls
Endpoint domain: Adverse events/effects
Primary endpoint: Social Distance Scale (SDS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Structured Clinical Interview for Diagnostic and Statistical Manual 5 (SCID-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic equivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Marginal adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With at least One Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: radiographic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported pain during standardized OARSI 30-second chair test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported pain during standardized OARSI 40m fast-paced walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported pain during standardized OARSI stair climb test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of hip redislocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Short-term repeatability of ADC maps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time shuttle run
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ureteral stent symptoms questionnaire (USSQ) index score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Evaluation of islet function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ocular Dominance Index (ODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of S-892216
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Plasma Concentration (Tmax) of S-892216
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of Carbamazepine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of Carbamazepine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Divided attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Development of Nipple Crack
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of weekly Physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Fruit and Vegetable Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Meat, Fish, Egg & Alternatives (MFEA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neonatal brain perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Predicted diagnosis accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline infant food reinforcing ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline conversational turns
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from Baseline Quality of parent-child interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient's safety associated with seizure-related accidents
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid refill at POD 30
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Opioid refill at POD 60
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Altered pain response from mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Positive or Negative ADHD Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Quality of Life- questionnaire (AAQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in Cutaneous Lupus Activity (CLA) Investigator Global Assessment (IGA) - Revised (R) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in the CLE Disease Area and Severity Index (CLASI)-Activity (A) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention satisfaction ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent CR (CR groups only)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent adherence to TRE (TRE groups only)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ADRB3 gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADRB3 protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycerol Measured Catecholamine Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Free Fatty Acid measured Catecholamine Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prolongation of the R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of 50% Improvement (ACR50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of successful inspiratory breaths attempts per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total number of inspiratory breaths achieved per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Area under the concentration-time curve of iclepertin in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of iclepertin in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Aldrete Scoring System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stage of AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Primary stability during placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Length of stay in PICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change from baseline in overall Spontaneous Bowel Movement (SBM) frequency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in stool consistency (Bristol Stool Form Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in straining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent change in Most Diseased segment Target-to-Background Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional Strength/Endurance as Measured by 30-second chair-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional Strength/Endurance as measured by six-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional Strength as measured by hand grip strength test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endogenous thrombin potential (area under the curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Peak height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: upper and lower limb function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Pathological Response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pathologic Complete Response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality of life after breast reconstruction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diagnosis of Pulmonary Embolism (PE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Body Fat Mass through DXA (percentage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting Glucose (mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to treatment instructions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of Patients with acceptable pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients with acceptable joint functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients with acceptable quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Anxiety scores from post-procedure questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: State-Trait Anxiety Inventory (STAI) scores - Baseline
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SAI-SF scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Osteoarthritis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Management of malignant biliary obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients with aetiological diagnosis from bronchoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of fibrin in the brains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: EASI-75 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy-related morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Concentration of SARS-CoV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of immune-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Abdominal Caliper
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of interleukin-1 beta in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Trans-plaque gradients for LOX-1 and CXCL1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liquid Biopsy System (LBS) performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Voluntary exercise duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal blood vessel density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of anxiety at one day after surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of anxiety at three days after surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of overall post-operative complications at 1 year
Endpoint domain: Adverse events/effects
Primary endpoint: Nipple-Areola Complex (NAC) Preservation Rate at 6 weeks after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Result of BREAST-QTM (Quality of life) at 1 year
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Beck Depression Inventory-II (BDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentrations of erythrocyte folate and serum folate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentrations of hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concentrations of vitamin B12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentrations of 7-chloro-kynurenic acid (7-Cl-KYNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF concentrations of 7-chloro-kynurenic acid (7-Cl-KYNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of 4-chloro-kynurenine (AV-101)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF concentrations of 4-chloro-kynurenine (AV-101)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment Scale for upper extremity assessment (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength assessed using the MRC (Medical Research Council Weakness Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Action Research Arm Test (ARAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number & severity of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Hallux valgus angle HVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Best corrected visual acuity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital admission rate of COVID-19 infection
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Absolute edema volume on day 14 after ICH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24 hours average ambulatory systolic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tolerability of extended dosing
Endpoint domain: Adverse events/effects
Primary endpoint: Total duration of treatment with strong opioids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Relative risk for hospitalization with dengue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent correct scores for consonant perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual assessment of stone-free status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of device - assessment of adverse events during the intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of device - assessment of adverse events during the follow up time
Endpoint domain: Adverse events/effects
Primary endpoint: T1rho value in normal grey and white matter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity promotion
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of CTCAE Grade 3 and above toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients who undergo a successful liver transplant
Endpoint domain: Mortality/survival
Primary endpoint: Inferior vena cava maximal diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of evaluable patients who are able to stay on maintenance therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor unit firing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak motor action potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quantification of Protein Concentrations in Cerebrospinal Fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maternal bonding assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 6 Weeks Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 12 Weeks Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consumer Assessment of Healthcare Providers and Systems Clinician and Group Survey (CG-CAHPS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Net Promotor Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of pericarditis recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Annualized change in HO volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events / Serious Adverse Events (AEs/SAE)
Endpoint domain: Adverse events/effects